The critical role of Th1-dominant immunity in tumor immunology - PubMed (original) (raw)
The critical role of Th1-dominant immunity in tumor immunology
T Nishimura et al. Cancer Chemother Pharmacol. 2000.
Abstract
To investigate the precise role of antigen-specific Th1 and Th2 cells in tumor immunity, we developed a novel adoptive tumor-immunotherapy model using OVA-specific Th1 and Th2 cells and an OVA gene-transfected tumor. This therapeutic model demonstrated that both antigen-specific Th1 and Th2 cells had strong antitumor activity in vivo with distinct mechanisms. However, immunological memory suitable for the generation of tumor-specific cytotoxic T lymphocytes was induced only when tumor-bearing mice received Th1 cell therapy, but not Th2 cell therapy. Thus it was strongly suggested that Th1-dominant immunity is critically important for the induction of antitumor cellular immunity in vivo. We also proposed that several immunomodulating protocols using interleukin (IL)-12, IL-12 gene, the natural killer T cell ligand alpha-galactosylceramide, or Th1 cytokine-conditioned dendritic cells might be useful strategies for the induction of Th1-dominant immunity essential for the development of tumor-specific immunotherapy.
Similar articles
- Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo.
Nishimura T, Iwakabe K, Sekimoto M, Ohmi Y, Yahata T, Nakui M, Sato T, Habu S, Tashiro H, Sato M, Ohta A. Nishimura T, et al. J Exp Med. 1999 Sep 6;190(5):617-27. doi: 10.1084/jem.190.5.617. J Exp Med. 1999. PMID: 10477547 Free PMC article. - Memory type 2 helper T cells induce long-lasting antitumor immunity by activating natural killer cells.
Kitajima M, Ito T, Tumes DJ, Endo Y, Onodera A, Hashimoto K, Motohashi S, Yamashita M, Nishimura T, Ziegler SF, Nakayama T. Kitajima M, et al. Cancer Res. 2011 Jul 15;71(14):4790-8. doi: 10.1158/0008-5472.CAN-10-1572. Epub 2011 Jun 6. Cancer Res. 2011. PMID: 21646476 - CD8 T cells inhibit IgE via dendritic cell IL-12 induction that promotes Th1 T cell counter-regulation.
Thomas MJ, Noble A, Sawicka E, Askenase PW, Kemeny DM. Thomas MJ, et al. J Immunol. 2002 Jan 1;168(1):216-23. doi: 10.4049/jimmunol.168.1.216. J Immunol. 2002. PMID: 11751965 - Th1 or Th2 balance regulated by interaction between dendritic cells and NKT cells.
Onoé K, Yanagawa Y, Minami K, Iijima N, Iwabuchi K. Onoé K, et al. Immunol Res. 2007;38(1-3):319-32. doi: 10.1007/s12026-007-0011-5. Immunol Res. 2007. PMID: 17917039 Review. - Advances in immunotherapy. Cellular and molecular bases of modern immunotherapy.
Goldman M. Goldman M. Acta Clin Belg. 1997;52(4):193-8. doi: 10.1080/17843286.1997.11718575. Acta Clin Belg. 1997. PMID: 9351289 Review. No abstract available.
Cited by
- Impaired Proliferation of CD8+ T Cells Stimulated with Monocyte-Derived Dendritic Cells Previously Matured with Thapsigargin-Stimulated LAD2 Human Mast Cells.
Kalkusova K, Taborska P, Stakheev D, Rataj M, Smite S, Darras E, Albo J, Bartunkova J, Vannucci L, Smrz D. Kalkusova K, et al. J Immunol Res. 2024 Jul 18;2024:5537948. doi: 10.1155/2024/5537948. eCollection 2024. J Immunol Res. 2024. PMID: 39056014 Free PMC article. - Corrigendum: Immunomodulatory function and anti-tumor mechanism of natural polysaccharides: a review.
Ying Y, Hao W. Ying Y, et al. Front Immunol. 2024 Jan 9;14:1361355. doi: 10.3389/fimmu.2023.1361355. eCollection 2023. Front Immunol. 2024. PMID: 38264646 Free PMC article. - Immunomodulatory Effect of a Polyherbal Formulation (Imusil) on Cyclophosphamide Induced Experimental Animal Model.
M R, S S, Jose SP, S S, Asish A, Jalam JK, Tilwani J, Jagmag T, Abhyankar M. M R, et al. Asian Pac J Cancer Prev. 2023 Nov 1;24(11):3729-3738. doi: 10.31557/APJCP.2023.24.11.3729. Asian Pac J Cancer Prev. 2023. PMID: 38019230 Free PMC article. - AKT inhibition generates potent polyfunctional clinical grade AUTO1 CAR T-cells, enhancing function and survival.
Mehra V, Agliardi G, Dias Alves Pinto J, Shafat MS, Garai AC, Green L, Hotblack A, Arce Vargas F, Peggs KS, van der Waart AB, Dolstra H, Pule MA, Roddie C. Mehra V, et al. J Immunother Cancer. 2023 Sep;11(9):e007002. doi: 10.1136/jitc-2023-007002. J Immunother Cancer. 2023. PMID: 37709295 Free PMC article. - TIME Is Ticking for Cervical Cancer.
Kumar V, Bauer C, Stewart JH 4th. Kumar V, et al. Biology (Basel). 2023 Jun 30;12(7):941. doi: 10.3390/biology12070941. Biology (Basel). 2023. PMID: 37508372 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources